drugset / Trial / NCT05118542

Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis

NCT05118542

Phase 3 Completed 36 enrolled Indonesia University
RandomizedParallel-groupTriple-blindTreatment

Summary

During July 2019 to August 2020, a single-blind clinical trial was done to 36 patients with Graves' disease. At the beginning of the study, subjects were accommodated into 2 groups, 17 into PTU groups and 19 into methimazole groups. There were 24 subjects who finished the study, 13 from PTU group and 11 from methimazole group. Blood serum was collected for HOMA-IR, LDL-R, NFĸB, sICAM-1, sVCAM-1 and sE-selectin examination. Meanwhile stiffness and thickness of carotid artery was measured using PWV and cIMT.

Timeline

Start
2019-01-01
Primary completion
2020-06-01
Completion
2020-08-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methimazole Small molecule
Comparator Propylthiouracil Small molecule